CryoPort Income from Continuous Operations 2010-2025 | CYRX
CryoPort income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
CryoPort Annual Income from Continuous Operations
(Millions of US $) |
| 2024 |
$-115 |
| 2023 |
$-100 |
| 2022 |
$-37 |
| 2021 |
$-276 |
| 2020 |
$-33 |
| 2019 |
$-18 |
| 2018 |
$-10 |
| 2017 |
$-8 |
| 2016 |
$-13 |
| 2016 |
$-10 |
| 2015 |
$-7 |
| 2014 |
$-20 |
| 2013 |
$-6 |
| 2012 |
$-8 |
| 2011 |
$-6 |
| 2010 |
$-6 |
| 2009 |
$-17 |
CryoPort Quarterly Income from Continuous Operations
(Millions of US $) |
| 2025-03-31 |
$-9 |
| 2024-12-31 |
$-23 |
| 2024-09-30 |
$1 |
| 2024-06-30 |
$-78 |
| 2024-03-31 |
$-15 |
| 2023-12-31 |
$-62 |
| 2023-09-30 |
$-13 |
| 2023-06-30 |
$-18 |
| 2023-03-31 |
$-6 |
| 2022-12-31 |
$-9 |
| 2022-09-30 |
$-5 |
| 2022-06-30 |
$-9 |
| 2022-03-31 |
$-13 |
| 2021-12-31 |
$-260 |
| 2021-09-30 |
$-7 |
| 2021-06-30 |
$-5 |
| 2021-03-31 |
$-4 |
| 2020-12-31 |
$-12 |
| 2020-09-30 |
$-11 |
| 2020-06-30 |
$-6 |
| 2020-03-31 |
$-4 |
| 2019-12-31 |
$-1 |
| 2019-09-30 |
$-12 |
| 2019-06-30 |
$-3 |
| 2019-03-31 |
$-2 |
| 2018-12-31 |
$-2 |
| 2018-09-30 |
$-2 |
| 2018-06-30 |
$-2 |
| 2018-03-31 |
$-3 |
| 2017-12-31 |
$-2 |
| 2017-09-30 |
$-2 |
| 2017-06-30 |
$-2 |
| 2017-03-31 |
$-2 |
| 2016-12-31 |
$-4 |
| 2016-09-30 |
$-2 |
| 2016-06-30 |
$-4 |
| 2016-03-31 |
$-3 |
| 2015-12-31 |
|
| 2015-09-30 |
$-2 |
| 2015-06-30 |
$-2 |
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2014-09-30 |
$-1 |
| 2014-06-30 |
$-2 |
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
$-15 |
| 2013-06-30 |
$-1 |
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
$-2 |
| 2012-06-30 |
$-2 |
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
$-2 |
| 2011-06-30 |
$-2 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$-2 |
| 2010-06-30 |
$-1 |
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
$-7 |
| 2009-06-30 |
$0 |
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Transportation |
Transportation - Services |
$0.374B |
$0.228B |
|
CryoPort, Inc. operates as a provider of shipping solutions comprising cold chain frozen shipping system for transporting biological, environmental and other temperature sensitive materials at temperatures below minus 150? Celsius. Its products include CryoPort Express Shippers, cryogenic dry vapor shippers capable of maintaining cryogenic temperatures; biological material holders for the shipment of infectious or dangerous goods; CryoPort Express System to programmatically manage order entry and various aspects of shipping operations; and CryoPort Express Analytics, to monitor shipment performance metrics and to evaluate temperature-monitoring data collected by the data logger during shipment. The Company's products find their application in the transportation of live cell pharmaceutical products, such as cancer vaccines, diagnostic materials, semen and embryos, and infectious substances. CryoPort, Inc. is based in Lake Forest, California.
|
